Global Omalizumab Biosimilars Market Growth 2022-2028

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Omalizumab Biosimilars Annual Sales 2017-2028
  • 2.1.2 World Current & Future Analysis for Omalizumab Biosimilars by Geographic Region, 2017, 2022 & 2028
  • 2.1.3 World Current & Future Analysis for Omalizumab Biosimilars by Country/Region, 2017, 2022 & 2028
• 2.2 Omalizumab Biosimilars Segment by Type
  • 2.2.1 150 mg/mL
  • 2.2.2 75 mg/0.5 mL
• 2.3 Omalizumab Biosimilars Sales by Type
  • 2.3.1 Global Omalizumab Biosimilars Sales Market Share by Type (2017-2022)
  • 2.3.2 Global Omalizumab Biosimilars Revenue and Market Share by Type (2017-2022)
  • 2.3.3 Global Omalizumab Biosimilars Sale Price by Type (2017-2022)
• 2.4 Omalizumab Biosimilars Segment by Application
  • 2.4.1 Persistent Asthma
  • 2.4.2 Nasal Polyps
  • 2.4.3 Chronic Idiopathic Urticaria
• 2.5 Omalizumab Biosimilars Sales by Application
  • 2.5.1 Global Omalizumab Biosimilars Sale Market Share by Application (2017-2022)
  • 2.5.2 Global Omalizumab Biosimilars Revenue and Market Share by Application (2017-2022)
  • 2.5.3 Global Omalizumab Biosimilars Sale Price by Application (2017-2022)

3 Global Omalizumab Biosimilars by Company

• 3.1 Global Omalizumab Biosimilars Breakdown Data by Company
  • 3.1.1 Global Omalizumab Biosimilars Annual Sales by Company (2020-2022)
  • 3.1.2 Global Omalizumab Biosimilars Sales Market Share by Company (2020-2022)
• 3.2 Global Omalizumab Biosimilars Annual Revenue by Company (2020-2022)
  • 3.2.1 Global Omalizumab Biosimilars Revenue by Company (2020-2022)
  • 3.2.2 Global Omalizumab Biosimilars Revenue Market Share by Company (2020-2022)
• 3.3 Global Omalizumab Biosimilars Sale Price by Company
• 3.4 Key Manufacturers Omalizumab Biosimilars Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Omalizumab Biosimilars Product Location Distribution
  • 3.4.2 Players Omalizumab Biosimilars Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Omalizumab Biosimilars by Geographic Region

• 4.1 World Historic Omalizumab Biosimilars Market Size by Geographic Region (2017-2022)
  • 4.1.1 Global Omalizumab Biosimilars Annual Sales by Geographic Region (2017-2022)
  • 4.1.2 Global Omalizumab Biosimilars Annual Revenue by Geographic Region
• 4.2 World Historic Omalizumab Biosimilars Market Size by Country/Region (2017-2022)
  • 4.2.1 Global Omalizumab Biosimilars Annual Sales by Country/Region (2017-2022)
  • 4.2.2 Global Omalizumab Biosimilars Annual Revenue by Country/Region
• 4.3 Americas Omalizumab Biosimilars Sales Growth
• 4.4 APAC Omalizumab Biosimilars Sales Growth
• 4.5 Europe Omalizumab Biosimilars Sales Growth
• 4.6 Middle East & Africa Omalizumab Biosimilars Sales Growth

5 Americas

• 5.1 Americas Omalizumab Biosimilars Sales by Country
  • 5.1.1 Americas Omalizumab Biosimilars Sales by Country (2017-2022)
  • 5.1.2 Americas Omalizumab Biosimilars Revenue by Country (2017-2022)
• 5.2 Americas Omalizumab Biosimilars Sales by Type
• 5.3 Americas Omalizumab Biosimilars Sales by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Omalizumab Biosimilars Sales by Region
  • 6.1.1 APAC Omalizumab Biosimilars Sales by Region (2017-2022)
  • 6.1.2 APAC Omalizumab Biosimilars Revenue by Region (2017-2022)
• 6.2 APAC Omalizumab Biosimilars Sales by Type
• 6.3 APAC Omalizumab Biosimilars Sales by Application
• 6.4 China
• 6.5 Japan
• 6.6 South Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 China Taiwan

7 Europe

• 7.1 Europe Omalizumab Biosimilars by Country
  • 7.1.1 Europe Omalizumab Biosimilars Sales by Country (2017-2022)
  • 7.1.2 Europe Omalizumab Biosimilars Revenue by Country (2017-2022)
• 7.2 Europe Omalizumab Biosimilars Sales by Type
• 7.3 Europe Omalizumab Biosimilars Sales by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Omalizumab Biosimilars by Country
  • 8.1.1 Middle East & Africa Omalizumab Biosimilars Sales by Country (2017-2022)
  • 8.1.2 Middle East & Africa Omalizumab Biosimilars Revenue by Country (2017-2022)
• 8.2 Middle East & Africa Omalizumab Biosimilars Sales by Type
• 8.3 Middle East & Africa Omalizumab Biosimilars Sales by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers & Growth Opportunities
• 9.2 Market Challenges & Risks
• 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

• 10.1 Raw Material and Suppliers
• 10.2 Manufacturing Cost Structure Analysis of Omalizumab Biosimilars
• 10.3 Manufacturing Process Analysis of Omalizumab Biosimilars
• 10.4 Industry Chain Structure of Omalizumab Biosimilars

11 Marketing, Distributors and Customer

• 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
• 11.2 Omalizumab Biosimilars Distributors
• 11.3 Omalizumab Biosimilars Customer

12 World Forecast Review for Omalizumab Biosimilars by Geographic Region

• 12.1 Global Omalizumab Biosimilars Market Size Forecast by Region
  • 12.1.1 Global Omalizumab Biosimilars Forecast by Region (2023-2028)
  • 12.1.2 Global Omalizumab Biosimilars Annual Revenue Forecast by Region (2023-2028)
• 12.2 Americas Forecast by Country
• 12.3 APAC Forecast by Region
• 12.4 Europe Forecast by Country
• 12.5 Middle East & Africa Forecast by Country
• 12.6 Global Omalizumab Biosimilars Forecast by Type
• 12.7 Global Omalizumab Biosimilars Forecast by Application

13 Key Players Analysis

• 13.1 Roche
  • 13.1.1 Roche Company Information
  • 13.1.2 Roche Omalizumab Biosimilars Product Offered
  • 13.1.3 Roche Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.1.4 Roche Main Business Overview
  • 13.1.5 Roche Latest Developments
• 13.2 Novartis
  • 13.2.1 Novartis Company Information
  • 13.2.2 Novartis Omalizumab Biosimilars Product Offered
  • 13.2.3 Novartis Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.2.4 Novartis Main Business Overview
  • 13.2.5 Novartis Latest Developments
• 13.3 Glenmark Pharmaceuticals
  • 13.3.1 Glenmark Pharmaceuticals Company Information
  • 13.3.2 Glenmark Pharmaceuticals Omalizumab Biosimilars Product Offered
  • 13.3.3 Glenmark Pharmaceuticals Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.3.4 Glenmark Pharmaceuticals Main Business Overview
  • 13.3.5 Glenmark Pharmaceuticals Latest Developments
• 13.4 Selexis
  • 13.4.1 Selexis Company Information
  • 13.4.2 Selexis Omalizumab Biosimilars Product Offered
  • 13.4.3 Selexis Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.4.4 Selexis Main Business Overview
  • 13.4.5 Selexis Latest Developments
• 13.5 Generium
  • 13.5.1 Generium Company Information
  • 13.5.2 Generium Omalizumab Biosimilars Product Offered
  • 13.5.3 Generium Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.5.4 Generium Main Business Overview
  • 13.5.5 Generium Latest Developments
• 13.6 CuraTeQ
  • 13.6.1 CuraTeQ Company Information
  • 13.6.2 CuraTeQ Omalizumab Biosimilars Product Offered
  • 13.6.3 CuraTeQ Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.6.4 CuraTeQ Main Business Overview
  • 13.6.5 CuraTeQ Latest Developments
• 13.7 Celltrion Healthcare
  • 13.7.1 Celltrion Healthcare Company Information
  • 13.7.2 Celltrion Healthcare Omalizumab Biosimilars Product Offered
  • 13.7.3 Celltrion Healthcare Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.7.4 Celltrion Healthcare Main Business Overview
  • 13.7.5 Celltrion Healthcare Latest Developments
• 13.8 Alvotech
  • 13.8.1 Alvotech Company Information
  • 13.8.2 Alvotech Omalizumab Biosimilars Product Offered
  • 13.8.3 Alvotech Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.8.4 Alvotech Main Business Overview
  • 13.8.5 Alvotech Latest Developments
• 13.9 BiosanaPharma
  • 13.9.1 BiosanaPharma Company Information
  • 13.9.2 BiosanaPharma Omalizumab Biosimilars Product Offered
  • 13.9.3 BiosanaPharma Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.9.4 BiosanaPharma Main Business Overview
  • 13.9.5 BiosanaPharma Latest Developments
• 13.10 Mabpharm
  • 13.10.1 Mabpharm Company Information
  • 13.10.2 Mabpharm Omalizumab Biosimilars Product Offered
  • 13.10.3 Mabpharm Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.10.4 Mabpharm Main Business Overview
  • 13.10.5 Mabpharm Latest Developments
• 13.11 CSPC Pharmaceutical Group
  • 13.11.1 CSPC Pharmaceutical Group Company Information
  • 13.11.2 CSPC Pharmaceutical Group Omalizumab Biosimilars Product Offered
  • 13.11.3 CSPC Pharmaceutical Group Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.11.4 CSPC Pharmaceutical Group Main Business Overview
  • 13.11.5 CSPC Pharmaceutical Group Latest Developments
• 13.12 Biomabs
  • 13.12.1 Biomabs Company Information
  • 13.12.2 Biomabs Omalizumab Biosimilars Product Offered
  • 13.12.3 Biomabs Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.12.4 Biomabs Main Business Overview
  • 13.12.5 Biomabs Latest Developments
• 13.13 HisunPharm
  • 13.13.1 HisunPharm Company Information
  • 13.13.2 HisunPharm Omalizumab Biosimilars Product Offered
  • 13.13.3 HisunPharm Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.13.4 HisunPharm Main Business Overview
  • 13.13.5 HisunPharm Latest Developments
• 13.14 Grand Pharm
  • 13.14.1 Grand Pharm Company Information
  • 13.14.2 Grand Pharm Omalizumab Biosimilars Product Offered
  • 13.14.3 Grand Pharm Omalizumab Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.14.4 Grand Pharm Main Business Overview
  • 13.14.5 Grand Pharm Latest Developments

14 Research Findings and Conclusion